• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

• 药品评价-临床研究 • 上一篇    下一篇

中药痛风汤联合非布司他治疗痛风合并高尿酸血症的临床效果观察

李秋霞   

  1. 河南省新郑市人民医院内五科
  • 收稿日期:2017-10-28 修回日期:2017-11-13 出版日期:2017-12-25 发布日期:2017-12-25

Clinical Effects of TCM Tongfeng Decoction and Febuxostat in Treatment of Gout Combined with Hyperuricemia

Li Qiuxia   

  1. Department of Internal Medicine, Xinzheng People’s Hospital in Henan Province
  • Received:2017-10-28 Revised:2017-11-13 Online:2017-12-25 Published:2017-12-25

摘要: 目的:观察中药痛风汤联合非布司他治疗痛风合并高尿酸血症的临床效果。结果:将我院80例痛风伴高尿酸血症患者随机分为对照组与观察组两组,各40例。对照组给予非布司他治疗,试验组给予中药痛风汤联合非布司他治疗。比较两组患者临床疗效、血尿酸(Blood uric acid,BUA)水平、C反应蛋白(C-reactionprotein,CRP)、白细胞介素-4(Interleukin,IL-4)水平及不良反应发生情况。结果:临床总有效率,试验组为97.5%,对照组为80.0%,试验组明显高于对照组(P<0.05);治疗后,两组血尿酸水平明显降低,且与对照组相比,试验组血尿酸水平(297.4±43.4) μmol?L-1较低,差异具有统计学意义(P<0.05);治疗后,两组IL-4、CRP水平明显降低,且与对照组相比,试验组IL-4 (31.7±4.4)ng?L-1、CRP (10.5±1.2)ng?mL-1水平较低,差异具有统计学意义(P<0.05);试验组肝功能异常、肌酐升高、恶心呕吐等不良反应发生率为10.0%稍低于对照组15.0%,两组比较无统计学差异(P>0.05)。结论:中药痛风汤联合非布司他治疗痛风合并高尿酸血症效果良好,可有效提升临床治疗效果,降低血清尿酸、炎症因子水平,且安全性高。

Abstract: Objective: To observe the clinical effects of Traditional Chinese Medicin(TCM) Tongfeng decoction and febuxostat in treatment of gout combined with hyperuricemia. Methods: 80 patients with gout combined with hyperuricemia were randomly divided into control group and observation group, 40 cases in each group. Control group was given febuxostat, while experimental group was treated with TCM Tongfeng decoction and febuxostat. The clinical efficacy, blood uric acid (BUA), C-reaction protein (CRP), interleukin-4 (IL-4) and adverse reactions were compared between the two groups. Results: The total effective rate of experimental group was 97.5%, which was higher than 80.0% of control group (P<0.05); After treatment, the BUA levels of two groups decreased, compared with control group, the BUA level of experimental group (297.4±43.4) μmol?L-1 was lower (P<0.05). After treatment, the levels of IL-4 and CRP in two groups decreased, compared with control group, the IL-4 and CRP levels in experimental group (31.7±4.4) ng?L-1, (10.5±1.2) ng?mL-1 were lower (P<0.05). The incidence of abnormal liver function, increased creatinine, nausea and vomiting in experimental group was 10.0%, which was slightly lower than 15.0% in control group, but there was no statistical difference (P>0.05). Conclusion: TCM Tongfeng decoction and febuxostat in treatment of gout combined with hyperuricemia is effective, it can increase clinical effects, decrease BUA and inflammatory factor, which has higher safety.